Quantbot Technologies LP purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 23,570 shares of the exchange traded fund’s stock, valued at approximately $2,237,000.
A number of other hedge funds also recently bought and sold shares of the stock. ICA Group Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $27,000. Scarborough Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at $32,000. BOCHK Asset Management Ltd purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at $36,000. Tennessee Valley Asset Management Partners acquired a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $44,000. Finally, Wetzel Investment Advisors Inc. acquired a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $45,000.
SPDR S&P Biotech ETF Price Performance
Shares of XBI traded up $0.99 during midday trading on Friday, reaching $98.95. 8,997,767 shares of the stock were exchanged, compared to its average volume of 10,524,539. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The company has a market capitalization of $7.54 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The business’s 50-day moving average price is $91.45 and its 200 day moving average price is $91.27.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- What is a buyback in stocks? A comprehensive guide for investors
- This Financial Stock’s Earnings Signal a Buying Opportunity
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.